# FDA Inspection 1002512 - AIRIS PHARMA PRIVATE LIMITED - January 31, 2017

Source: https://www.keypedia.com/records/fda_inspections/airis-pharma-private-limited/b86bbfe7-d68c-4e5e-8799-d0e6d4a6e6c8
Source feed: FDA_Inspections

> FDA Inspection 1002512 for AIRIS PHARMA PRIVATE LIMITED on January 31, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002512
- Company Name: AIRIS PHARMA PRIVATE LIMITED
- Inspection Date: 2017-01-31
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1228622 - 2024-02-03](https://www.keypedia.com/records/fda_inspections/airis-pharma-private-limited/8d3d39f3-fb15-49b4-90bd-a2a0cfbaf3be)

Company: https://www.keypedia.com/companies/airis-pharma-private-limited/fcbdc54b-e886-4781-a723-bf4bcf9c537d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c